# Leica Microsystems Sponsored PMCF Study to Collect and Confirm Clinical Data on the Performance of the GLOW400 Device When Used in Accordance With Its Intended Use

> **NCT07366892** · — · NOT_YET_RECRUITING · sponsor: **Leica Microsystems (Schweiz) AG** · enrollment: 37 (estimated)

## Conditions studied

- Suspected Grade III and IV Gliomas Requiring Surgical Intervention
- Neurosurgical Procedure
- Glioma
- Glioblastoma (GBM)

## Interventions

- **DEVICE:** GLOW400 is a digital surgical microscope accessory used in fluorescent visualization of suspected grade III or IV gliomas during neurosurgery.

## Key facts

- **NCT ID:** NCT07366892
- **Lead sponsor:** Leica Microsystems (Schweiz) AG
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-02-01
- **Primary completion:** 2026-12-20
- **Final completion:** 2027-05-31
- **Target enrollment:** 37 (ESTIMATED)
- **Last updated:** 2026-01-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07366892

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07366892, "Leica Microsystems Sponsored PMCF Study to Collect and Confirm Clinical Data on the Performance of the GLOW400 Device When Used in Accordance With Its Intended Use". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07366892. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*